Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 911, 2020 01 22.
Artigo em Inglês | MEDLINE | ID: mdl-31969575

RESUMO

The practice of prophylactic administration of a macrolide antimicrobial with rifampin (MaR) to apparently healthy foals with pulmonary lesions identified by thoracic ultrasonography (i.e., subclinically pneumonic foals) is common in the United States. The practice has been associated epidemiologically with emergence of R. equi resistant to MaR. Here, we report direct evidence of multi-drug resistance among foals treated with MaR. In silico and in vitro analysis of the fecal microbiome and resistome of 38 subclinically pneumonic foals treated with either MaR (n = 19) or gallium maltolate (GaM; n = 19) and 19 untreated controls was performed. Treatment with MaR, but not GaM, significantly decreased fecal microbiota abundance and diversity, and expanded the abundance and diversity of antimicrobial resistance genes in feces. Soil plots experimentally infected with Rhodococcus equi (R. equi) and treated with MaR selected for MaR-resistant R. equi, whereas MaR-susceptible R. equi out-competed resistant isolates in GaM-treated or untreated plots. Our results indicate that MaR use promotes multi-drug resistance in R. equi and commensals that are shed into their environment where they can persist and potentially infect or colonize horses and other animals.


Assuntos
Antibacterianos/efeitos adversos , Antibacterianos/farmacologia , Antibioticoprofilaxia , Resistência a Múltiplos Medicamentos/efeitos dos fármacos , Resistência a Múltiplos Medicamentos/genética , Doenças dos Cavalos/prevenção & controle , Macrolídeos/efeitos adversos , Macrolídeos/uso terapêutico , Compostos Organometálicos/efeitos adversos , Compostos Organometálicos/uso terapêutico , Pneumonia Bacteriana/prevenção & controle , Pneumonia Bacteriana/veterinária , Pironas/efeitos adversos , Pironas/uso terapêutico , Rhodococcus equi/efeitos dos fármacos , Rifampina/efeitos adversos , Rifampina/uso terapêutico , Animais , Antibacterianos/uso terapêutico , Fezes/microbiologia , Cavalos , Macrolídeos/farmacologia , Testes de Sensibilidade Microbiana , Compostos Organometálicos/farmacologia , Pneumonia Bacteriana/microbiologia , Pironas/farmacologia , Rhodococcus equi/genética , Rifampina/farmacologia
2.
J Bacteriol ; 194(24): 6790-801, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23042997

RESUMO

Rhodococcus equi is a facultative intracellular, Gram-positive, soilborne actinomycete which can cause severe pyogranulomatous pneumonia with abscessation in young horses (foals) and in immunocompromised people, such as persons with AIDS. All strains of R. equi isolated from foals and approximately a third isolated from humans contain a large, ~81-kb plasmid which is essential for the intramacrophage growth of the organism and for virulence in foals and murine in vivo model systems. We found that the entire virulence plasmid could be transferred from plasmid-containing strains of R. equi (donor) to plasmid-free R. equi strains (recipient) at a high frequency and that plasmid transmission reestablished the capacity for intracellular growth in macrophages. Plasmid transfer required living cells and cell-to-cell contact and was unaffected by the presence of DNase, factors pointing to conjugation as the major means of genetic transfer. Deletion of a putative relaxase-encoding gene, traA, located in the proposed conjugative region of the plasmid, abolished plasmid transfer. Reversion of the traA mutation restored plasmid transmissibility. Finally, plasmid transmission to other Rhodococcus species and some additional related organisms was demonstrated. This is the first study showing a virulence plasmid transfer in R. equi, and it establishes a mechanism by which the virulence plasmid can move among bacteria in the soil.


Assuntos
Conjugação Genética , Plasmídeos/genética , Rhodococcus equi/genética , Rhodococcus equi/patogenicidade , Infecções por Actinomycetales/microbiologia , Infecções por Actinomycetales/patologia , Infecções por Actinomycetales/veterinária , Animais , Proteínas de Bactérias/genética , DNA Bacteriano/genética , Desoxirribonucleases/metabolismo , Transferência Genética Horizontal , Doenças dos Cavalos/microbiologia , Cavalos , Macrófagos/microbiologia , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...